|
Sale Of Makena (Details) (USD $)
|
0 Months Ended | 3 Months Ended | 9 Months Ended | 0 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Jan. 08, 2010
|
Jan. 16, 2008
|
Jan. 16, 2008
|
Jun. 25, 2011
|
Mar. 26, 2011
|
Jun. 26, 2010
|
Jun. 25, 2011
|
Jun. 26, 2010
|
Feb. 03, 2011
|
Feb. 03, 2011
Previously Received [Member]
Parent Company [Member]
|
|
| Transaction price of sale of intellectual property assets | $ 82,000,000 | |||||||||
| Transaction price amounts received | 9,500,000 | 79,500,000 | ||||||||
| Gain on sale of intellectual property, net | 84,500,000 | 84,502,000 | ||||||||
| Amended transaction price as a result of executing amendment | 199,500,000 | |||||||||
| Amount received upon signing of the amendment | 70,000,000 | |||||||||
| Additional amount to be received upon FDA approval | 25,000,000 | 12,500,000 | ||||||||
| Additional amount to be received beginning one year from FDA approval | 95,000,000 | 12,500,000 | ||||||||
| Additional amount to be received in 18 to 30 month period | $ 95,000,000 | |||||||||
| Royalty on sales due | 5.00% | |||||||||